Status:
COMPLETED
Hepatitis B Virus (HBV) Prevention for Homeless at Risk for HBV/Hepatitis C Virus (HCV)/HIV
Lead Sponsor:
University of California, Los Angeles
Conditions:
Hepatitis B
Hepatitis C
Eligibility:
MALE
18-39 years
Phase:
NA
Brief Summary
In this study, researchers from UCLA and Friends Community Center will work together in designing a program to assist young homeless stimulant-using gay and bisexual homeless men to complete the hepat...
Detailed Description
Homeless adults are at high risk for Hepatitis B virus (HBV), Hepatitis C virus (HCV) and HIV infection due to high rates of injection drug use and unprotected sexual activity. Our NIDA-funded RO1 awa...
Eligibility Criteria
Inclusion
- homeless males self-reporting gay or bisexual behaviors in the last 12 months
- age 18-39
- methamphetamine and/or cocaine/crack use currently or in the last three months
- no self-reported participation in drug treatment in the last 30 days
- willing to provide informed consent
- willing to undergo hepatitis B and C and HIV antibody testing at baseline
- found to be HBV antibody negative
Exclusion
- persons with Guillian Barre, or allergy to yeast or neomycin
- monolingual speakers of languages other than English or Spanish
- persons judged to be cognitively impaired by the nurse
Key Trial Info
Start Date :
July 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2015
Estimated Enrollment :
451 Patients enrolled
Trial Details
Trial ID
NCT00926146
Start Date
July 1 2009
End Date
February 1 2015
Last Update
January 30 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Friends Community Center
Los Angeles, California, United States, 90028